Mayo Clinic researchers say breast cancer survival improves Herceptin used with chemotherapy
Saturday, December 12, 2009 - 09:49
in Health & Medicine
SAN ANTONIO -- Using Herceptin with chemotherapy, instead of after, clearly improves treatment of women with HER2+ breast cancer, and should be the new standard of care, says a Mayo Clinic researcher who led what is regarded to be a key clinical trial determining the best use of Herceptin. Link: http://www.mayoclinic.org/news